Maike Zimmermann

Maike Zimmermann is a Senior Scientist at Truvian since January 2021, focusing on assay development for Immuno Assays within the company's point-of-care blood test platform. Previous roles include Scientist II at Truvian, contributing to the development of an automated benchtop FDA-cleared system for rapid lab-accurate results, and a Scientist in Cell Biology at Epirium Bio, working on therapeutics for mitochondrial function. As a Co-Founder of Oomni, Maike aimed to enhance chemotherapy efficacy while minimizing toxicity. Additional experience as a Biochemist at Accelerated Medical Diagnostic involved creating diagnostic assays for chemotherapy responses, and a Postdoctoral Fellow at UC Davis Medical Center focused on drug resistance mechanisms in various cancers. Maike's academic background includes a Dr. rer. nat. in Biochemistry from Bielefeld University and training at institutions such as UC Davis and the University of Iowa.